Cargando…
Prognostic Value of Vimentin in Triple Negative Breast Cancer Patients Depends on Chemotherapy Regimen and p53 Mutant Expression
PURPOSE: To determine the prognostic value of vimentin in triple negative breast cancer (TNBC) patients, specifically in relation to chemotherapy regimen and p53 mutant expression. PATIENT AND METHODS: We retrospectively analyzed the association of pre-treatment tumor expression of vimentin with 48-...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390761/ https://www.ncbi.nlm.nih.gov/pubmed/37533591 http://dx.doi.org/10.2147/BCTT.S418696 |